351.
Recombinant Env proteins that bind the quaternary-specific, V1/V2-directed PGT antibodies
J
Gorman,
J
McLellan,
Y
Yang,
T
Zhou,
J
Zhu,
S
Bangaru,
N
Bayless,
P
Alff,
CP
Marshall,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):P84 (13 September 2012)
Full text | PDF
352.
Structural comparison of somatically related PG9 and PG16 in complex with their epitope reveals differences in glycan recognition
M
Pancera,
JS
McLellan,
S
Shahzad-ul-Hussan,
N
Doria-Rose,
B
Zhang,
Y
Yang,
DR
Burton,
WC
Koff,
CA
Bewley,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):P74 (13 September 2012)
Full text | PDF
353.
rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses
P
Bart,
Y
Huang,
N
Frahm,
S
Karuna,
M
Allen,
NK
Kochar,
S
Chappuis,
J
Gaillard,
B
Graham,
G
Pantaleo
Retrovirology 2012, 9 (Suppl 2):O72 (13 September 2012)
Full text | PDF
354.
Detection of antibodies to the α 4β 7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay
M
Rao,
N
Karasavvas,
A
Pinter,
H
Liao,
M
Bonsignori,
B
Mathieson,
S
Zolla-Pazner,
BF
Haynes,
NL
Michael,
JH
Kim,
CR
Alving,
KK
Peachman
Retrovirology 2012, 9 (Suppl 2):P71 (13 September 2012)
Full text | PDF
355.
Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies
M
Joyce,
B
Zhang,
T
Zhou,
S
Moquin,
X
Wu,
M
Louder,
Z
Zhang,
I
Georgiev,
J
Zhu,
L
Shapiro,
JR
Mascola,
GJ
Nabel,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):P68 (13 September 2012)
Full text | PDF
356.
Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120
T
Zhou,
S
Moquin,
R
Lynch,
X
Wu,
J
Zhu,
Y
Yang,
B
Zhang,
JR
Mascola,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):P57 (13 September 2012)
Full text | PDF
357.
Design of epitope-specific probes for sera analysis and antibody isolation
I
Georgiev,
P
Acharya,
SD
Schmidt,
Y
Li,
D
Wycuff,
G
Ofek,
N
Doria-Rose,
TS
Luongo,
Y
Yang,
T
Zhou,
BR
Donald,
JR
Mascola,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):P50 (13 September 2012)
Full text | PDF
358.
454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8
G
Ofek,
J
Zhu,
Y
Yang,
B
Zhang,
K
Mckee,
M
Louder,
J
Huang,
L
Laub,
M
Connors,
J
Mascola,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):O40 (13 September 2012)
Full text | PDF
359.
Deep sequencing with longitudinal sampling of a VRC01-like-antibody response in a chronically infected individual
Z
Zhang,
X
Wu,
N
Longo,
B
Zhang,
J
Zhu,
C
NISC,
JC
Mullikin,
L
Wu,
GJ
Nabel,
M
Connors,
PD
Kwong,
JR
Mascola,
L
Shapiro
Retrovirology 2012, 9 (Suppl 2):O36 (13 September 2012)
Full text | PDF
360.
Structure-guided modification and optimization of antibody VRC07
Y
Kwon,
I
Georgiev,
S
O'Dell,
W
Shi,
G
Chuang,
Y
Yang,
B
Zhang,
J
Zhu,
GJ
Nabel,
JR
Mascola,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):O34 (13 September 2012)
Full text | PDF
361.
Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
L
Liao,
M
Bonsignori,
K
Hwang,
AM
Moody,
R
Park,
S
Crawford,
H
Chen,
TL
Jeffries,
M
Cooper,
X
Lu,
R
De,
N
Karasavvas,
S
Rerks-Ngarm,
S
Nitayaphan,
J
Kaewkungwal,
S
Tovanabutra,
P
Pitisuttithum,
J
Tartaglia,
F
Sinangil,
J
Kim,
NL
Michael,
GD
Tomaras,
Z
Yang,
K
Dai,
M
Pancera,
GJ
Nabel,
JR
Mascola,
PD
Kwong,
A
Pinter,
S
Zolla-Pazner,
MS
Alam,
BF
Haynes
et al.
Retrovirology 2012, 9 (Suppl 2):O31 (13 September 2012)
Full text | PDF
362.
A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies
NA
Doria-Rose,
I
Georgiev,
RP
Staupe,
S
O'Dell,
G
Chuang,
J
Gorman,
JS
McLellan,
M
Pancera,
M
Bonsignori,
BF
Haynes,
DR
Burton,
WC
Koff,
PD
Kwong,
JR
Mascola
Retrovirology 2012, 9 (Suppl 2):O29 (13 September 2012)
Full text | PDF
363.
Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site
K
Dai,
JC
Boyington,
W
Shi,
SD
Schmidt,
I
Georgiev,
D
Lingwood,
PD
Kwong,
JR
Mascola,
Z
Yang,
GJ
Nabel
Retrovirology 2012, 9 (Suppl 2):P23 (13 September 2012)
Full text | PDF
364.
The functional comorbidity index had high inter-rater reliability in patients with acute lung injury
Eddy
Fan,
Jeneen
M
Gifford,
Satish
Chandolu,
Elizabeth
Colantuoni,
Peter
J
Pronovost,
Dale
M
Needham
BMC Anesthesiology 2012, 12 :21 (13 September 2012)
Abstract | Full text | PDF | PubMed
365.
NMR spectroscopy of HIV-1 gp120 outer domain
M
Sastry,
L
Xu,
S
Bhattacharya,
GJ
Nabel,
CA
Bewley,
PD
Kwong
Retrovirology 2012, 9 (Suppl 2):P20 (13 September 2012)
Full text | PDF
366.
Infiltration of dendritic cells and antigen uptake in the muscle after injection of HIV-1 Env gp120 in adjuvant
F
Liang,
KJ
Sandgren,
H
Fausther-Bovendo,
D
O'hagan,
A
Seubert,
E
De Gregorio,
S
Rao,
N
Sullivan,
RA
Seder,
RA
Koup,
K
Loré
Retrovirology 2012, 9 (Suppl 2):O16 (13 September 2012)
Full text | PDF
367.
RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
NP
Liyanage,
P
Pegu,
S
Gordon,
M
Cameron,
K
Foulds,
M
Doster,
M
Vaccari,
R
Koup,
M
Roederer,
R
Sékaly,
G
Franchini
Retrovirology 2012, 9 (Suppl 2):O14 (13 September 2012)
Full text | PDF
368.
Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
G
Franchini,
P
Pegu,
S
Gordon,
B
Keele,
M
Doster,
Y
Guan,
G
Ferrari,
R
Pal,
MG
Ferrari,
S
Whitney,
L
Hudacik,
E
Billings,
M
Rao,
D
Montefiori,
D
Venzon,
C
Fenizia,
J
Lifson,
D
Stablein,
J
Tartaglia,
N
Michael,
J
Kim
Retrovirology 2012, 9 (Suppl 2):O2 (13 September 2012)
Full text | PDF
369.
Ranked retrieval of segmented nuclei for objective assessment of cancer gene repositioning
William
J
Cukierski,
Kaustav
Nandy,
Prabhakar
Gudla,
Karen
J
Meaburn,
Tom
Misteli,
David
J
Foran,
Stephen
J
Lockett
BMC Bioinformatics 2012, 13 :232 (12 September 2012)
Abstract | Full text | PDF | PubMed
370.
Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer
Christopher
H
Switzer,
Robert
Y-S
Cheng,
Lisa
A
Ridnour,
Sharon
A
Glynn,
Stefan
Ambs,
David
A
Wink
Breast Cancer Research 2012, 14 :R125 (12 September 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
371.
Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
Peter
Kellman,
Joel
R
Wilson,
Hui
Xue,
W
Bandettini,
Sujata
M
Shanbhag,
Kirk
M
Druey,
Martin
Ugander,
Andrew
E
Arai
Journal of Cardiovascular Magnetic Resonance 2012, 14 :64 (11 September 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
372.
Effects of a 6-month multimodal training intervention on retention of functional fitness in older adults: A randomized-controlled cross-over design
Janus
Gudlaugsson,
Vilmundur
Gudnason,
Thor
Aspelund,
Kristin
Siggeirsdottir,
Anna
S
Olafsdottir,
Palmi
V
Jonsson,
Sigurbjorn
A
Arngrimsson,
Tamara
B
Harris,
Erlingur
Johannsson
International Journal of Behavioral Nutrition and Physical Activity 2012, 9 :107 (10 September 2012)
Abstract | Full text | PDF | PubMed
373.
Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method
Peter
Kellman,
Joel
R
Wilson,
Hui
Xue,
Martin
Ugander,
Andrew
E
Arai
Journal of Cardiovascular Magnetic Resonance 2012, 14 :63 (10 September 2012)
Abstract | Full text | PDF | PubMed
374.
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study
Sara
Galimberti,
Francesca
Guerrini,
Flavia
Salvi,
Iacopo
Petrini,
Daniela
Gioia,
Emanuela
Messa,
Giuseppe A
Palumbo,
Daniela
Cilloni,
Mario
Petrini,
Alessandro
Levis
Journal of Hematology & Oncology 2012, 5 :53 (10 September 2012)
Abstract | Full text | PDF | PubMed
375.
A molecular computational model improves the preoperative diagnosis of thyroid nodules
Sara
Tomei,
Ivo
Marchetti,
Katia
Zavaglia,
Francesca
Lessi,
Alessandro
Apollo,
Paolo
Aretini,
Giancarlo
Di Coscio,
Generoso
Bevilacqua,
Chiara
Mazzanti
BMC Cancer 2012, 12 :396 (7 September 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
A molecular computational model based on the expression of 8 genes can preoperatively distinguish benign from malignant thyroid lesions and could help identify patients with thyroid nodules who do not require radical surgery.